EW - Edwards Lifesciences Corporation

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
48.12B
Enterprise Value 3
48.18B
Trailing P/E
63.34
Forward P/E 1
37.45
PEG Ratio (5 yr expected) 1
3.29
Price/Sales (ttm)
11.59
Price/Book (mrq)
12.61
Enterprise Value/Revenue 3
11.60
Enterprise Value/EBITDA 6
37.89

Trading Information

Stock Price History

Beta (5Y Monthly) 0.80
52-Week Change 343.83%
S&P500 52-Week Change 320.83%
52 Week High 3247.64
52 Week Low 3139.64
50-Day Moving Average 3238.61
200-Day Moving Average 3214.43

Share Statistics

Avg Vol (3 month) 31.17M
Avg Vol (10 day) 31.78M
Shares Outstanding 5208.57M
Float 207.07M
% Held by Insiders 13.94%
% Held by Institutions 10.00%
Shares Short (Nov 15, 2019) 42.08M
Short Ratio (Nov 15, 2019) 41.8
Short % of Float (Nov 15, 2019) 41.12%
Short % of Shares Outstanding (Nov 15, 2019) 41.00%
Shares Short (prior month Oct 15, 2019) 42.76M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/2
Last Split Date 3Dec 14, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin 18.64%
Operating Margin (ttm)28.57%

Management Effectiveness

Return on Assets (ttm)12.43%
Return on Equity (ttm)21.56%

Income Statement

Revenue (ttm)4.15B
Revenue Per Share (ttm)19.94
Quarterly Revenue Growth (yoy)20.70%
Gross Profit (ttm)2.78B
EBITDA 1.27B
Net Income Avi to Common (ttm)773.7M
Diluted EPS (ttm)3.64
Quarterly Earnings Growth (yoy)21.60%

Balance Sheet

Total Cash (mrq)1.36B
Total Cash Per Share (mrq)6.51
Total Debt (mrq)670.7M
Total Debt/Equity (mrq)17.58
Current Ratio (mrq)3.53
Book Value Per Share (mrq)18.30

Cash Flow Statement

Operating Cash Flow (ttm)1.07B
Levered Free Cash Flow (ttm)647.92M